Clinical outcomes of nirmatrelvir-ritonavir use in pregnant women during the Omicron wave of the coronavirus disease 2019 pandemic

• Główni autorzy: Chih-Wei Lin (Autor), Yu-Ling Liang (Autor), Ming-Ta Chuang (Autor), Chun-Han Tseng (Autor), Pei-Yin Tsai (Autor), Mei-Tsz Su (Autor)
• Format: Książka
• Wydane: Elsevier, 2023-12-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background: Paxlovid is an oral drug composed of nirmatrelvir and ritonavir that has been demonstrated to be effective in decreasing the risk of severe coronavirus disease 2019 (COVID-19). Here, we report the use of paxlovid in pregnant women with COVID-19. Methods: Pregnant women attending a tertia...